Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson’s disease
Journal of Lipid Research · 2026-01 · 67 (1) · 100955
DOI: 10.1016/j.jlr.2025.100955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2026-01. Verfasst von Yu-Fong Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; The Metabolomics Core Laboratory, NTU Centers of Genomic and Pre…. Hauptthemen laut MEDLINE: Parkinson Disease, Ceramides, Glycosphingolipids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University, National Science and Technology Council.
Abstract (Originalsprache)
Alterations in sphingolipid metabolism have been implicated in the pathogenesis of Parkinson's disease (PD), yet findings regarding peripheral sphingolipid changes remain inconsistent. This study aimed to elucidate the metabolic profiles of plasma ceramides and glycosphingolipids (GSLs) in patients with PD. We recruited 250 patients with PD and 250 age- and sex-matched neurologically healthy controls. Plasma ceramide and GSL species were quantified using liquid chromatography‒tandem mass spectrometry, complemented by a meta-analysis of the gene expression levels of relevant enzymes in the substantia nigra obtained from Gene Expression Omnibus. A total of 119 sphingolipids were analyzed. Significant differences in plasma sphingolipid species were observed, including increased GSLs and decreased dihydroceramides. Incorporation of 35 significantly altered sphingolipid species enabled discrimination of patients with PD from controls with an AUC of 0.80 (P < 0.0001). Notable alterations in lipid ratios were detected, with increases in the monohexosylceramide-to-ceramide ratio as well as the monosialodihexosylganglioside-to-dihexosylceramide and trihexosylceramide-to-dihexosylceramide ratios. We also observed a higher ceramide-to-dihydroceramide ratio and shifts in ceramide characteristics, reflecting changes in the ceramide synthesis pathway. Supporting these findings, meta-analysis revealed changes in the expression of relevant enzymes, including decreased expression of lysosomal hydrolases, such as β-glucocerebrosidase and α-galactosidase, reinforcing the impaired GSL degradation and alteration in ceramide synthesis observed in PD. Our results suggest that altered peripheral ceramide and GSL profiles can discriminate PD from controls. Moreover, we highlight disrupted GSL and ceramide metabolism in PD patients, emphasizing the need for further research to explore the implications of these metabolic disturbances in PD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; The Metabolomics Core Laboratory, NTU Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Department of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College…
- Ph.D. Program in Translational Medicine, National Taiwan University and Academia Sinica, Taipei, Taiwan; Department of Neurology, National Taiwan University Hospital Jinshan Branch, New Taipei City, Taiwan.
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Biomedical Engineering, College of Medical Science and Technology, National Taiwan University, Taipei, Taiwan; Institut…
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan; The Metabolomics Core Laboratory, NTU Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan; Departmen…
Förderung
- National Taiwan University
- National Science and Technology Council
Zitieren
APA
Peng, Y. F., Chen, S. J., Li, J. L., Lin, C. H., & Kuo, C. H. (2026). Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson’s disease. Journal of Lipid Research, 67(1), 100955. https://doi.org/10.1016/j.jlr.2025.100955
Vancouver
Peng YF, Chen SJ, Li JL, Lin CH, Kuo CH. Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson’s disease. Journal of Lipid Research. 2026;67(1):100955. doi:10.1016/j.jlr.2025.100955
BibTeX
@article{Peng2026,
author = {Peng, Yu-Fong and Chen, Szu-Ju and Li, Jeng-Lin and Lin, Chin-Hsien and Kuo, Ching-Hua},
title = {Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson’s disease},
journal = {Journal of Lipid Research},
year = {2026},
volume = {67},
number = {1},
pages = {100955},
doi = {10.1016/j.jlr.2025.100955}
}
EUVIMED